PL1853700T3 - Koekspresja przez rekombinowanie podjednostki 1 reduktazy epoksydu witaminy K w celu poprawy ekspresji białka zależnego od witaminy K - Google Patents

Koekspresja przez rekombinowanie podjednostki 1 reduktazy epoksydu witaminy K w celu poprawy ekspresji białka zależnego od witaminy K

Info

Publication number
PL1853700T3
PL1853700T3 PL06706455T PL06706455T PL1853700T3 PL 1853700 T3 PL1853700 T3 PL 1853700T3 PL 06706455 T PL06706455 T PL 06706455T PL 06706455 T PL06706455 T PL 06706455T PL 1853700 T3 PL1853700 T3 PL 1853700T3
Authority
PL
Poland
Prior art keywords
vitamin
expression
recombinant
dependent protein
improve
Prior art date
Application number
PL06706455T
Other languages
English (en)
Inventor
Friedrich Scheiflinger
Ernst Boehm
Original Assignee
Baxalta Inc
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36130202&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1853700(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta Inc, Baxalta GmbH filed Critical Baxalta Inc
Publication of PL1853700T3 publication Critical patent/PL1853700T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y117/00—Oxidoreductases acting on CH or CH2 groups (1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
PL06706455T 2005-02-28 2006-01-27 Koekspresja przez rekombinowanie podjednostki 1 reduktazy epoksydu witaminy K w celu poprawy ekspresji białka zależnego od witaminy K PL1853700T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65704105P 2005-02-28 2005-02-28
PCT/EP2006/000734 WO2006089613A1 (en) 2005-02-28 2006-01-27 Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression
EP06706455A EP1853700B1 (en) 2005-02-28 2006-01-27 Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression

Publications (1)

Publication Number Publication Date
PL1853700T3 true PL1853700T3 (pl) 2013-05-31

Family

ID=36130202

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06706455T PL1853700T3 (pl) 2005-02-28 2006-01-27 Koekspresja przez rekombinowanie podjednostki 1 reduktazy epoksydu witaminy K w celu poprawy ekspresji białka zależnego od witaminy K

Country Status (17)

Country Link
US (2) US9617523B2 (pl)
EP (2) EP1853700B1 (pl)
JP (3) JP2008531026A (pl)
KR (2) KR20130025952A (pl)
CN (2) CN103396998A (pl)
AU (1) AU2006218216B2 (pl)
BR (1) BRPI0607751A8 (pl)
CA (1) CA2599284A1 (pl)
DK (1) DK1853700T3 (pl)
ES (1) ES2397530T3 (pl)
HR (1) HRP20130028T1 (pl)
IL (1) IL184696A (pl)
MX (2) MX349285B (pl)
PL (1) PL1853700T3 (pl)
PT (1) PT1853700E (pl)
SI (1) SI1853700T1 (pl)
WO (1) WO2006089613A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453222A (en) 1994-09-15 1995-09-26 Glitsch, Inc. Contact tray apparatus and method
DE602004025157D1 (de) * 2003-09-23 2010-03-04 Univ North Carolina Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
DE602004026897D1 (de) 2003-10-14 2010-06-10 Baxter Healthcare Sa Vkorc1 (vitamin k epoxide recycling polypeptide), ein therapeutisches ziel für coumarin und deren derivate
PL1853700T3 (pl) 2005-02-28 2013-05-31 Baxalta Inc Koekspresja przez rekombinowanie podjednostki 1 reduktazy epoksydu witaminy K w celu poprawy ekspresji białka zależnego od witaminy K
CA2601574C (en) * 2005-03-15 2014-12-02 University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin k-dependent proteins
AU2006320168B2 (en) * 2005-12-02 2012-02-23 Wake Forest University Health Sciences Compositions and methods for increasing production of recombinant gamma-carboxylated proteins
AU2006331501B2 (en) * 2005-12-21 2013-09-05 Aptevo Biotherapeutics Llc Method of producing biologically active vitamin K dependent proteins by recombinant methods
DK2280734T3 (da) 2008-04-24 2014-05-26 Cantab Biopharmaceuticals Patents Ltd Faktor-ix-konjugater med forlængede halveringstider
EP2451963B1 (en) * 2009-07-10 2014-04-30 CSL Limited Method of increasing the expression yield of vitamin k-dependent proteins
US9631002B2 (en) 2010-12-21 2017-04-25 The University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin K-dependent proteins
JP2012139232A (ja) * 2012-03-15 2012-07-26 Univ Of North Carolina At Chapel Hill 活性ビタミンｋ依存性タンパク質を生産するための方法及び組成物
RU2535871C1 (ru) * 2013-07-10 2014-12-20 Общество с ограниченной ответственностью "Лаборатория медицинской биотехнологии" (ООО "ЛМБТ") Плазмида для экспрессии в клетке китайского хомячка, клетка китайского хомячка - продуцент белка с Gla-доменом и способ получения белка с Gla-доменом
JP2014221048A (ja) * 2014-06-16 2014-11-27 ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 活性ビタミンｋ依存性タンパク質を生産するための方法及び組成物
CN104293737B (zh) * 2014-09-16 2017-06-13 太原博奥特生物技术有限公司 一种包含表达功能性重组人凝血因子ⅶ载体的宿主细胞及其高水平表达方法
ES2803773T3 (es) 2015-12-02 2021-01-29 CSL Behring Lengnau AG Medios mejorados para la expresión de proteínas recombinantes dependientes de vitamina k

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822584D0 (en) 1988-09-27 1988-11-02 Abco Technology Ltd Steam boiler system
WO1991001372A1 (en) 1989-07-17 1991-02-07 New England Medical Center Hospitals, Inc. VITAMIN K-DEPENDENT η-CARBOXYLASE
AU8427091A (en) 1990-07-23 1992-02-18 Zymogenetics Inc. Gamma-carboxylase and methods of use
US5268275A (en) 1991-05-08 1993-12-07 The University Of North Carolina At Chapel Hill Vitamin K-dependent carboxylase
CA2332307A1 (en) 1998-07-10 2000-01-20 Incyte Pharmaceuticals, Inc. Human transport protein homologs
BR0114373A (pt) 2000-10-02 2004-02-17 Novo Nordisk As Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante
EP1379264A4 (en) 2001-03-21 2009-07-08 Human Genome Sciences Inc HUMAN SECRETED PROTEINS
DE602004025157D1 (de) 2003-09-23 2010-03-04 Univ North Carolina Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
DE602004026897D1 (de) 2003-10-14 2010-06-10 Baxter Healthcare Sa Vkorc1 (vitamin k epoxide recycling polypeptide), ein therapeutisches ziel für coumarin und deren derivate
US20090100533A1 (en) 2004-12-21 2009-04-16 Novo Nordisk Health Care Ag Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host sytems
PL1853700T3 (pl) 2005-02-28 2013-05-31 Baxalta Inc Koekspresja przez rekombinowanie podjednostki 1 reduktazy epoksydu witaminy K w celu poprawy ekspresji białka zależnego od witaminy K
CA2601574C (en) * 2005-03-15 2014-12-02 University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin k-dependent proteins

Also Published As

Publication number Publication date
SI1853700T1 (sl) 2013-02-28
MX349285B (es) 2017-07-20
JP2008531026A (ja) 2008-08-14
JP2011142923A (ja) 2011-07-28
PT1853700E (pt) 2013-01-14
JP2013063089A (ja) 2013-04-11
CN101124320A (zh) 2008-02-13
HRP20130028T1 (hr) 2013-02-28
HK1113498A1 (en) 2008-10-03
JP5339391B2 (ja) 2013-11-13
EP2295547B1 (en) 2017-09-20
US9617523B2 (en) 2017-04-11
IL184696A0 (en) 2007-12-03
EP2295547A1 (en) 2011-03-16
US20060194284A1 (en) 2006-08-31
KR20070110106A (ko) 2007-11-15
WO2006089613A1 (en) 2006-08-31
CN103396998A (zh) 2013-11-20
IL184696A (en) 2013-09-30
EP1853700A1 (en) 2007-11-14
AU2006218216A1 (en) 2006-08-31
EP1853700B1 (en) 2012-10-24
BRPI0607751A2 (pt) 2010-03-16
CA2599284A1 (en) 2006-08-31
MX2007010489A (es) 2007-11-08
KR20130025952A (ko) 2013-03-12
BRPI0607751A8 (pt) 2015-10-27
AU2006218216B2 (en) 2011-01-20
DK1853700T3 (da) 2013-01-07
US20170226487A1 (en) 2017-08-10
ES2397530T3 (es) 2013-03-07
KR101310532B1 (ko) 2013-09-23

Similar Documents

Publication Publication Date Title
IL184696A0 (en) Recombinant co-experssion of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression
KR101434673B9 (ko) 할리콘드린 ｂ 유사체의 제조를 위한 중간체
EP1730313A4 (en) INCREASING THE PERFORMANCE OF PROTEIN EXPRESSION IN PROTEIN SYNTHESIS ACELLULAR SYSTEMS BY ADDITION OF ANTI-FOAM AGENTS
ZA200900229B (en) Refolding of recombinant proteins
MY151036A (en) Synthesis of (r)-n-methylnaltrexone
ZA200800899B (en) Production of canola protein
PT1880008E (pt) Expressão de proteína mitocondrial através de uma abordagem alotópica melhorada
ZA200710382B (en) Recombinant yeasts for synthesizing epoxide hydrolases
EP1861507A4 (en) OPTIMIZATION OF THE EXPRESSION OF HETEROLOGOUS POLYPEPTIDES
IL181185A0 (en) Novel polymorphs of azabicyclohexane
WO2007038678A8 (en) Analogs of ghrelin
FR2908771B1 (fr) Chitine-glucane d'extrait fongique de granulometrie fine
GB0502985D0 (en) Therapeutic uses of tomato extracts
GB0426160D0 (en) Production of proteins
TWI347935B (en) Isomerisation of pharmaceutical intermediates
IL188449A0 (en) Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease
IL183106A0 (en) Production of proteins
EP1868636A4 (en) USE OF RECOMBINANT SUPERCOMPOSE INTERFERONS
PL1730108T3 (pl) Stereoselektywna synteza analogów witaminy D
TWI368621B (en) Stereoselective synthesis of β-nucleosides
GB0412186D0 (en) Production of recombinant protein
GB2426765A8 (en) Induction of multipotent stem cells from monocytes
SI1942891T1 (sl) Nova kombinacija zdravil kot antidepresiv
HK1115608A (en) Recombinant yeasts for synthesizing epoxide hydrolases
AU2004905841A0 (en) Preparation of Gold Surfaces